Nanopath Raises $25M Series B to Accelerate Vaginitis Test and Pipeline

Norwest and SV Health lead a $25M Series B for Nanopath to scale manufacturing and begin FDA 510(k) work on its 15-minute vaginitis test, with plans to extend to UTIs and STIs.